Annual ROA
-42.88%
-8.14%-23.43%
December 31, 2023
Summary
- As of February 7, 2025, ABUS annual return on assets is -42.88%, with the most recent change of -8.14% (-23.43%) on December 31, 2023.
- During the last 3 years, ABUS annual ROA has risen by +9.67% (+18.40%).
- ABUS annual ROA is now -129.09% below its all-time high of 147.42%, reached on December 31, 2006.
Performance
ABUS ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROA
-50.87%
-2.09%-4.28%
September 30, 2024
Summary
- As of February 7, 2025, ABUS quarterly return on assets is -50.87%, with the most recent change of -2.09% (-4.28%) on September 30, 2024.
- Over the past year, ABUS quarterly ROA has dropped by -5.59% (-12.35%).
- ABUS quarterly ROA is now -135.24% below its all-time high of 144.37%, reached on December 31, 2012.
Performance
ABUS Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
ABUS ROA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -23.4% | -12.3% |
| 3 y3 years | +18.4% | -54.8% |
| 5 y5 years | -74.7% | -54.8% |
ABUS ROA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -23.4% | +4.0% | -54.8% | at low |
| 5 y | 5-year | -23.4% | +53.5% | -54.8% | +53.6% |
| alltime | all time | -129.1% | +53.5% | -135.2% | +53.6% |
Arbutus Biopharma ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -50.87%(+4.3%) |
| Jun 2024 | - | -48.78%(+7.7%) |
| Mar 2024 | - | -45.28%(+7.7%) |
| Dec 2023 | -42.88%(+23.4%) | -42.04%(+3.2%) |
| Sep 2023 | - | -40.75%(+9.9%) |
| Jun 2023 | - | -37.09%(+10.5%) |
| Mar 2023 | - | -33.57%(+2.1%) |
| Dec 2022 | -34.74%(-22.2%) | -32.87%(-2.0%) |
| Sep 2022 | - | -33.53%(-8.8%) |
| Jun 2022 | - | -36.76%(-13.6%) |
| Mar 2022 | - | -42.56%(-11.9%) |
| Dec 2021 | -44.65%(-15.0%) | -48.33%(-3.9%) |
| Sep 2021 | - | -50.30%(-9.0%) |
| Jun 2021 | - | -55.27%(+2.5%) |
| Mar 2021 | - | -53.90%(-2.9%) |
| Dec 2020 | -52.55%(-43.0%) | -55.53%(-13.7%) |
| Sep 2020 | - | -64.38%(-41.3%) |
| Jun 2020 | - | -109.73%(+10.6%) |
| Mar 2020 | - | -99.24%(+10.1%) |
| Dec 2019 | -92.20%(+275.7%) | -90.16%(+21.5%) |
| Sep 2019 | - | -74.22%(+91.5%) |
| Jun 2019 | - | -38.75%(+51.5%) |
| Mar 2019 | - | -25.57%(+12.7%) |
| Dec 2018 | -24.54%(-25.4%) | -22.69%(-22.9%) |
| Sep 2018 | - | -29.44%(+21.8%) |
| Jun 2018 | - | -24.18%(-26.2%) |
| Mar 2018 | - | -32.76%(-0.9%) |
| Dec 2017 | -32.90%(-57.7%) | -33.07%(-61.5%) |
| Sep 2017 | - | -85.98%(+15.3%) |
| Jun 2017 | - | -74.58%(-11.6%) |
| Mar 2017 | - | -84.37%(+20.2%) |
| Dec 2016 | -77.75%(+414.9%) | -70.18%(+159.3%) |
| Sep 2016 | - | -27.06%(+2.5%) |
| Jun 2016 | - | -26.39%(+193.2%) |
| Mar 2016 | - | -9.00%(-10.6%) |
| Dec 2015 | -15.10%(-63.1%) | -10.07%(-17.9%) |
| Sep 2015 | - | -12.27%(+14.1%) |
| Jun 2015 | - | -10.75%(-14.8%) |
| Mar 2015 | - | -12.62%(-61.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | -40.90%(+80.7%) | -33.16%(-4.0%) |
| Sep 2014 | - | -34.53%(-8.5%) |
| Jun 2014 | - | -37.73%(-10.5%) |
| Mar 2014 | - | -42.14%(+58.3%) |
| Dec 2013 | -22.63%(-125.3%) | -26.62%(-140.3%) |
| Sep 2013 | - | 66.12%(-22.6%) |
| Jun 2013 | - | 85.46%(-21.3%) |
| Mar 2013 | - | 108.58%(-24.8%) |
| Dec 2012 | 89.33%(-253.8%) | 144.37%(-273.8%) |
| Sep 2012 | - | -83.05%(+40.3%) |
| Jun 2012 | - | -59.18%(-10.2%) |
| Mar 2012 | - | -65.91%(+7.7%) |
| Dec 2011 | -58.08%(+14.6%) | -61.18%(+26.1%) |
| Sep 2011 | - | -48.52%(+9.2%) |
| Jun 2011 | - | -44.42%(+13.0%) |
| Mar 2011 | - | -39.32%(-0.5%) |
| Dec 2010 | -50.69%(+113.3%) | -39.53%(+19.4%) |
| Sep 2010 | - | -33.10%(+1.1%) |
| Jun 2010 | - | -32.74%(+20.3%) |
| Mar 2010 | - | -27.21%(+34.6%) |
| Dec 2009 | -23.77%(-31.9%) | -20.22%(+21.9%) |
| Sep 2009 | - | -16.59%(-23.4%) |
| Jun 2009 | - | -21.67%(-27.9%) |
| Mar 2009 | - | -30.04%(+2.7%) |
| Dec 2008 | -34.89%(+108.5%) | -29.24%(+4.2%) |
| Sep 2008 | - | -28.06%(+171.6%) |
| Jun 2008 | - | -10.33%(-25.0%) |
| Mar 2008 | - | -13.78%(+17.8%) |
| Dec 2007 | -16.73%(-111.3%) | -11.70%(-10.1%) |
| Sep 2007 | - | -13.02%(-32.6%) |
| Jun 2007 | - | -19.33% |
| Dec 2006 | 147.42%(-645.0%) | - |
| Dec 2005 | -27.05%(-55.7%) | - |
| Dec 2004 | -61.09%(+3.7%) | - |
| Dec 2003 | -58.89%(+15.2%) | - |
| Dec 2002 | -51.10%(+82.6%) | - |
| Dec 2001 | -27.99%(-6.8%) | - |
| Dec 2000 | -30.02%(-18.0%) | - |
| Dec 1999 | -36.62%(-33.8%) | - |
| Dec 1998 | -55.29% | - |
FAQ
- What is Arbutus Biopharma annual return on assets?
- What is the all time high annual ROA for Arbutus Biopharma?
- What is Arbutus Biopharma annual ROA year-on-year change?
- What is Arbutus Biopharma quarterly return on assets?
- What is the all time high quarterly ROA for Arbutus Biopharma?
- What is Arbutus Biopharma quarterly ROA year-on-year change?
What is Arbutus Biopharma annual return on assets?
The current annual ROA of ABUS is -42.88%
What is the all time high annual ROA for Arbutus Biopharma?
Arbutus Biopharma all-time high annual return on assets is 147.42%
What is Arbutus Biopharma annual ROA year-on-year change?
Over the past year, ABUS annual return on assets has changed by -8.14% (-23.43%)
What is Arbutus Biopharma quarterly return on assets?
The current quarterly ROA of ABUS is -50.87%
What is the all time high quarterly ROA for Arbutus Biopharma?
Arbutus Biopharma all-time high quarterly return on assets is 144.37%
What is Arbutus Biopharma quarterly ROA year-on-year change?
Over the past year, ABUS quarterly return on assets has changed by -5.59% (-12.35%)